Phase I/II study of carboplatin plus nab-paclitaxel plus bevacizumab administered to advanced non-squamous non-small cell lung cancer.
Phase of Trial: Phase I/II
Latest Information Update: 12 May 2016
At a glance
- Drugs Paclitaxel (Primary) ; Bevacizumab; Carboplatin
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 20 Mar 2014 New trial record